According to the recent report “Nanotechnology Drug Delivery Market: By Technology (Nanocrystals, Nanoparticles, Others), By Application (Neurology, Oncology, Anti-infective, Others) & By Region-Forecast (2017-2022)”, published by IndustryARC, estimates that North America will continue its dominance till the end of the forecast period.
The Nanotechnology Drug Delivery Market deals with the development of nanotechnology in drug delivery. Nanotechnology drug delivery is a new technology which is developed to deliver drugs to treat diseases. Generally, this technology is used in health-care applications like neurology, oncology, cardiovascular disorders, Anti-infective and some others.
Based on the technology, Nanotechnology Drug Delivery Market is segmented as nanocrystals, nanoparticles, liposomes, micelles, nanotubes and others. Among all, the nanoparticles segment has dominated the market. The nanotubes segment is expected to expand and to register high growth rate during the forecast period. One important and active application area of nanotechnology drug delivery systems is to transport drugs to the final location of therapeutic intervention within the body.
Scope & Regional Forecast of the Nanotechnology Drug Delivery Market
Various factors like development of efficient and advanced nanotechnology, expanding the research on nano drug delivery system, growing government initiatives and increasing awareness among people are the major growth drivers of the Nanotechnology Drug Delivery Market. In addition, rising demand for novel drug delivery is also drives significant growth for the market. This market is expected to register high growth due to rising chronic diseases like cancer and diabetes.
However, higher production cost and higher costs for research and development are the major restrains for the market growth. But, increasing adoption of nanotechnology in drug delivery in emerging nations like India and China are the creating many growth opportunities for the Nanotechnology Drug Delivery Market. Among all the applications, neurology procedures holds the highest market shares.
North America is dominating the Nanotechnology Drug Delivery Market, due to high medical reimbursement facilities and technological advancement. Asia-Pacific is holding the second position followed by Europe. Also, Asia-Pacific is projected to register the fastest growth due to rapidly increasing population, modernized health-care infrastructure and growing medical tourism industry in emerging nations like India and China.
Request For TOC @ http://industryarc.com/pdfdownload.php?id=16071
Segmentations & Key Players Involved in the Nanotechnology Drug Delivery Market
The Nanotechnology Drug Delivery Market can be broken down into various segmentations on the basis of –
Technology: Nanocrystals, Nanoparticles, Liposomes, Micelles, Nanotubes and Others.
Application: Neurology, Oncology, Cardiovascular/Physiology, Anti-inflammatory/Immunology, Anti-infective and Others.
Region: Europe, Asia-Pacific, North America and Rest of the World.
Some of the key players involved in the Nanotechnology Drug Delivery Market are as follows:
Novartis International AG
Why buy this report?
* The overall market has been consolidated from the perspective of different geographic locations and key economies for this market.
* Identifies growth sectors and factors driving or constraining the market.
* The market is analyzed based on the key attributes such as the power in the hands of producers and consumers, analysis on the degree of competition, and threats from substitutes and new entrants.
* The study includes the demand of this particular market on a global and regional scale for a five year period of 2017 – 2022, to assess how the market will develop.
Make an Inquiry @ http://industryarc.com/inquiry-before-buying.php?id=16071
Company Name: IndustryARC
Contact Person: Mr. Venkateshwar Reddy
Phone: 1-614-588-8538 (Ext: 101)
Country: United States